Boston-based neurotechnology company Neurable has raised $35 million in Series A funding to accelerate the commercialization of Neurable AI, its patented, compact brain-computer interface technology designed to integrate into everyday consumer devices.
According to a company announcement on Friday, the round was led by Spectrum Moonshot Fund and brings Neurable’s total funding to $65 million.
Neurable aims to embed noninvasive brain-signal processing into devices people already use, making cognitive insights as accessible as common health metrics like heart rate or sleep quality. By doing so, the company is working to move brain health monitoring out of specialized settings and into daily life.
The funding follows the recent launch of the MW75 Neuro LT headphones and a redesigned Neurable app, which together provide users with real-time insights into mental fatigue, focus and cognitive recovery.
“With the MW75 Neuro LT and the redesigned Neurable app, people can finally see how their mind performs throughout the day. This funding allows us to scale Neurable AI into new devices and new industries, making cognitive health an accessible, daily utility for everyone,” Dr. Ramses Alcaide, CEO of Neurable, said in a statement.
